Patents expiring in 2040

US 10596260

Reoviruses having modified sequences

ONCOLYTICS BIOTECH INC. · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10600528

Process for producing Gallium-68 through the irradiation of a solution target

Ion Beam Applications · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10598665

Analysis of genomic DNA, RNA, and proteins in exosomes for diagnosis and theranosis

The Board of Regents of the University of Texas System · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10597732

Allogeneic autophagosome-enriched composition for the treatment of disease

Providence Health & Services—Oregon · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10597731

Allogeneic autophagosome-enriched composition for the treatment of disease

Providence Health & Services—Oregon · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10597680

Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription

The Regents of the University of California · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10597657

RNAi agents and compositions for inhibiting expression of apolipoprotein C-III (APOC3)

Arrowhead Pharmaceuticals, Inc. · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10597661

Polynucleotide agents targeting patatin-like phospholipase domain containing 3 (PNPLA3) and methods of use thereof

Alnylam Pharmaceuticals, Inc. · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10597455

Methods and compositions for treating and preventing disease associated with alpha-v beta-8 integrin

The Regents of the University of California · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10597660

Compositions and methods of treating amyotrophic lateral sclerosis (ALS)

VOYAGER THERAPEUTICS, INC. · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10596275

Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells

Aura Biosciences, Inc. · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10597448

Methods for treating visceral pain associated with interstitial cystitis by administering antagonist antibodies directed against calcitonin gene-related peptide

TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10597415

Pentaaza macrocyclic ring complexes possessing oral bioavailability

Galera Labs, LLC · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10597391

Urea-containing isoxazole derivatives as FXR agonists and methods of use thereof

Enanta Pharmaceuticals, Inc. · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10597392

Tetrahydropyridopyrazines as modulators of GPR6

Takeda Pharmaceutical Company Limited · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10597384

Solid forms of 3-(6-(1-(2,2-difluorobenzo[D][1,3]dioxol-5-yl)cyclopropanecarboxamido)-3-methylpyridin-2-yl) benzoic acid

Vertex Pharmaceuticals Incorporated · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10597367

Metabotropic glutamate receptor negative allosteric modulators (NAMs) and uses thereof

SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10596359

Therapeutic agent preparations into a lumen of the intestinal tract using a swallowable drug delivery device

Rani Therapeutics, LLC · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10597377

Somatostatin modulators and uses thereof

CRINETICS PHARMACEUTICALS, INC. · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10596227

Polypeptide targeting to mitochondria

United Kingdom Research and Innovation · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10596247

Methods and compositions for attenuated chlamydia as vaccine and vector

The Board of Regents of the University of Texas System · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10596217

Compositions containing a Withania somnifera extract incubated with a filamentous fungus of the Beauvaria genus

ETHNODYNE · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10596216

Use of a Withania extract for the treatment of amyloid-related diseases

Ethnodyne and Centre National de la Recherche Scientifique (CNRS) · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10597340

Synthesis of fluorinated radiopharmaceuticals via electrochemical fluorination

The Regents of the University of California · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10596158

Solid forms of {[5-(3-chlorophenyl)-3-hydroxypyridine-2-carbonyl]amino}acetic acid, compositions, and uses thereof

Akebia Therapeutics, Inc. · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10596185

Flavonoid compositions and uses thereof

The United States of America, as represented by the Secretary of Agriculture · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10596125

Nanowire-coated microdevice and method of making and using the same

The Regents of the University of California · Granted Tue Mar 24 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 19 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

WO 2020058405

ASSOCIATIONS PHARMACEUTIQUES DESTINÉES À ÊTRE UTILISÉES DANS LE TRAITEMENT DU CANCER

BASILEA PHARM INT AG [CH] · Granted Thu Mar 26 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Wed Mar 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10604585

Modulation of PTPRA to treat arthritis

The Regents of the University of California · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10604548

Minicircle DNA vector vaccine platform for foot-and-mouth disease and methods thereof

The Government of the United States of America, as represented by the Secretary of Homeland Security · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10604493

Compositions, methods of use, and methods of treatment

The Regents of the University of California · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10604507

Melanocortin subtype-2 receptor (MC2R) antagonists and uses thereof

CRINETICS PHARMACEUTICALS, INC. · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10603296

Compositions and methods for diagnosis and treatment of neuromuscular disorders

United States of America as represented by the Secretary of the Air Force · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10603308

Methods and compositions for treatment of epileptic disorders

OVID THERAPEUTICS INC. · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10603311

Use of pridopidine to improve cognitive function and for treating Alzheimer's disease

The Board of Regents of the University of Texas System · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10604807

Methods for diagnosing and assessing treatment for Cushing's syndrome

Corcept Therapeutics Incorporated · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10604806

Methods of diagnosing chronic obstructive pulmonary disease (COPD) using novel molecular biomarkers

Transgenion—International Institute for Regenerative Translational Medicine GmbH · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10604533

Heterocycle amines and uses thereof

Ligand Pharmaceuticals Incorporated · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10603326

Pharmaceutical formulation of 3α-ethynyl-3β-hydroxyandrostan-17-one oxime

Umecrine Cognition AB · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10604582

Anti-CD276 antibodies (B7H3)

The United States of America, as represented by the Secretary, Department of Health · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10604565

Monoclonal antibodies to growth and differentiation factor 15 (GDF-15), and uses thereof for treating cancer cachexia and cancer

Julius-Maximilians-Universitat Wurzburg · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10604537

Solid state forms of ixazomib citrate

TEVA PHARMACEUTICALS INTERNATIONAL GMBH · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10604771

Delivery methods and compositions for nuclease-mediated genome engineering

Sangamo Therapeutics, Inc. · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10604520

N-acyl amino acid compounds and methods of use

Pliant Therapeutics, Inc. · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10604516

Compounds for imaging tau proteins that accumulate in the brain

National Institutes for Quantum and Radiological Science and Technology · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10603356

Compositions and method for treatment of inflammatory bowel disease

The Regents of the University of California · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10604499

MYC G-quadruplex stabilizing small molecules and their use

The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

US 10604758

Therapeutic oligomers for treating amyloidosis

ARCTURUS THERAPEUTICS, INC. · Granted Tue Mar 31 2020 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 26 2040 00:00:00 GMT+0000 (Coordinated Universal Time)